Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter clinical study | Zendy

Takahiro Wakasaki | Zendy; Tomomi Manako | Zendy; Ryuji Yasumatsu | Zendy; Hirotaka Hara | Zendy; Satoshi Toh | Zendy; Muneyuki Masuda | Zendy; Moriyasu Yamauchi | Zendy; Yuichiro Kuratomi | Zendy; Emi K. Nishimura | Zendy; Toranoshin Takeuchi | Zendy; Mioko Matsuo | Zendy; Rina Jiromaru | Zendy; Kazuki Hashimoto | Zendy; Noritaka Komune | Zendy; Takashi Nakagawa | Zendy

Open Access

Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter clinical study

Author(s) -

Takahiro Wakasaki,

Tomomi Manako,

Ryuji Yasumatsu,

Hirotaka Hara,

Satoshi Toh,

Muneyuki Masuda,

Moriyasu Yamauchi,

Yuichiro Kuratomi,

Emi K. Nishimura,

Toranoshin Takeuchi,

Mioko Matsuo,

Rina Jiromaru,

Kazuki Hashimoto,

Noritaka Komune,

Takashi Nakagawa

Publication year - 2022

Publication title -

plos one

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.99

H-Index - 332

ISSN - 1932-6203

DOI - 10.1371/journal.pone.0271907

Subject(s) - medicine , cetuximab , oncology , head and neck squamous cell carcinoma , chemotherapy , adverse effect , salvage therapy , incidence (geometry) , head and neck cancer , radiation therapy , cancer , physics , colorectal cancer , optics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research